Applied DNA Sciences (APDN) Cash Flow Statement

Click line-items for a historical chart and %

Net loss
Depreciation and amortization	706.5K
Fair value of vested options issued to officers, directors and employees
Amortization of capitalized financing costs
Amortization of debt discount attributable to convertible debentures
Equity based compensation	2.04M
Common stock issued in settlement of interest
Decrease in accounts receivable	-2.6M
Decrease (increase) in prepaid expenses and deposits	16.21K
Increase in accounts payable and accrued liabilities	-253.33K
Net cash used in operating activities
Cash flows from investing activities:
Net proceeds from related party advances
Net proceeds from issuance of convertible notes
Net cash provided by financing activities
Net increase in cash and cash equivalents	-2.83M
Cash and cash equivalents at beginning of period	7.31M
Cash and cash equivalents at end of period	4.48M
Cash paid during the period for interest	0
Cash paid during the period for taxes	0
Fair value of warrants issued for financing costs
Common stock issued in exchange for previously incurred debt	0

Entities mentioned with APDN

View All Entities